List of Excipients in API celecoxib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing celecoxib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | CELEBREX | celecoxib | 0025-1515 | CROSCARMELLOSE SODIUM | |
| PFIZER LABORATORIES DIV PFIZER INC | CELEBREX | celecoxib | 0025-1515 | GELATIN | |
| PFIZER LABORATORIES DIV PFIZER INC | CELEBREX | celecoxib | 0025-1515 | LACTOSE MONOHYDRATE | |
| PFIZER LABORATORIES DIV PFIZER INC | CELEBREX | celecoxib | 0025-1515 | MAGNESIUM STEARATE | |
| PFIZER LABORATORIES DIV PFIZER INC | CELEBREX | celecoxib | 0025-1515 | POVIDONE | |
| PFIZER LABORATORIES DIV PFIZER INC | CELEBREX | celecoxib | 0025-1515 | SODIUM LAURYL SULFATE | |
| Blenheim Pharmacal Inc | CELECOXIB | celecoxib | 10544-917 | CROSCARMELLOSE SODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing celecoxib
Detailed excipient profiles for celecoxib
Excipient focus: ACESULFAME POTASSIUM
celecoxib drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing ACESULFAME POTASSIUM
Excipient focus: ALCOHOL
celecoxib drug variants containing ALCOHOL
celecoxib drug variants not containing ALCOHOL
Excipient focus: AMMONIA
celecoxib drug variants containing AMMONIA
celecoxib drug variants not containing AMMONIA
Excipient focus: AMMONIUM GLYCYRRHIZATE
celecoxib drug variants containing AMMONIUM GLYCYRRHIZATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing AMMONIUM GLYCYRRHIZATE
Excipient focus: BANANA
celecoxib drug variants containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing BANANA
Excipient focus: BUTYL ALCOHOL
celecoxib drug variants containing BUTYL ALCOHOL
celecoxib drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
celecoxib drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COPOVIDONE K25-31
celecoxib drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSCARMELLOSE SODIUM
celecoxib drug variants containing CROSCARMELLOSE SODIUM
celecoxib drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| Macleods Pharmaceuticals Limited | celecoxib | 33342-155 |
| RxChange Co | celecoxib | 33358-902 |
| QPharma Inc | celecoxib | 42708-016 |
| PD-Rx Pharmaceuticals Inc | celecoxib | 43063-825 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
celecoxib drug variants containing CROSPOVIDONE
celecoxib drug variants not containing CROSPOVIDONE
Excipient focus: D&C RED NO. 28
celecoxib drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| Mylan Institutional Inc | celecoxib | 51079-199 |
| Golden State Medical Supply Inc | celecoxib | 60429-459 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing D&C RED NO. 28
Excipient focus: D&C RED NO. 33
celecoxib drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| QPharma Inc | celecoxib | 42708-016 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing D&C RED NO. 33
Excipient focus: D&C RED NO. 7
celecoxib drug variants containing D&C RED NO. 7
| Company | Ingredient | NDC |
|---|---|---|
| Qingdao BAHEAL Pharmaceutical Co Ltd | celecoxib | 70247-006 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing D&C RED NO. 7
Excipient focus: D&C YELLOW NO. 10
celecoxib drug variants containing D&C YELLOW NO. 10
celecoxib drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIMETHICONE
celecoxib drug variants containing DIMETHICONE
celecoxib drug variants not containing DIMETHICONE
Excipient focus: FD&C BLUE NO. 1
celecoxib drug variants containing FD&C BLUE NO. 1
celecoxib drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
celecoxib drug variants containing FD&C BLUE NO. 2
celecoxib drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 3
celecoxib drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | celecoxib | 43353-257 |
| Chartwell RX LLC | celecoxib | 62135-021 |
| Yiling Pharmaceutical Inc | celecoxib | 69117-0020 |
| EMC PHARMA LLC | celecoxib | 81288-020 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
celecoxib drug variants containing FD&C RED NO. 40
celecoxib drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
celecoxib drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | celecoxib | 29300-157 |
| Amneal Pharmaceuticals LLC | celecoxib | 65162-817 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | celecoxib | 70247-006 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
celecoxib drug variants containing FERRIC OXIDE RED
celecoxib drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
celecoxib drug variants containing FERRIC OXIDE YELLOW
celecoxib drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
celecoxib drug variants containing FERROSOFERRIC OXIDE
celecoxib drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
celecoxib drug variants containing GELATIN
celecoxib drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
celecoxib drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing GLYCERIN
Excipient focus: GLYCERYL MONOCAPRYLATE
celecoxib drug variants containing GLYCERYL MONOCAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing GLYCERYL MONOCAPRYLATE
Excipient focus: HYDROXYPROPYL CELLULOSE
celecoxib drug variants containing HYDROXYPROPYL CELLULOSE
celecoxib drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: ISOPROPYL ALCOHOL
celecoxib drug variants containing ISOPROPYL ALCOHOL
celecoxib drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
celecoxib drug variants containing LACTOSE MONOHYDRATE
celecoxib drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| RxChange Co | celecoxib | 33358-902 |
| QPharma Inc | celecoxib | 42708-016 |
| PD-Rx Pharmaceuticals Inc | celecoxib | 43063-825 |
| A-S Medication Solutions | celecoxib | 50090-5178 |
| >Company | >Ingredient | >NDC |
Excipient focus: LAUROYL PEG-32 GLYCERIDES
celecoxib drug variants containing LAUROYL PEG-32 GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing LAUROYL PEG-32 GLYCERIDES
Excipient focus: LEVOMENTHOL
celecoxib drug variants containing LEVOMENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing LEVOMENTHOL
Excipient focus: MAGNESIUM STEARATE
celecoxib drug variants containing MAGNESIUM STEARATE
celecoxib drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
celecoxib drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| QPharma Inc | celecoxib | 42708-016 |
| Unit Dose Services | celecoxib | 50436-3982 |
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing MANNITOL
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
celecoxib drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: PEPPERMINT
celecoxib drug variants containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing PEPPERMINT
Excipient focus: POLYETHYLENE GLYCOL
celecoxib drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYOXYL 35 CASTOR OIL
celecoxib drug variants containing POLYOXYL 35 CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POLYOXYL 35 CASTOR OIL
Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL
celecoxib drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POLYOXYL 40 HYDROGENATED CASTOR OIL
Excipient focus: POTASSIUM HYDROXIDE
celecoxib drug variants containing POTASSIUM HYDROXIDE
celecoxib drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
celecoxib drug variants containing POVIDONE
celecoxib drug variants not containing POVIDONE
Excipient focus: POVIDONE K12
celecoxib drug variants containing POVIDONE K12
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Cardinal Health 107 LLC | celecoxib | 55154-7645 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POVIDONE K12
Excipient focus: POVIDONE K30
celecoxib drug variants containing POVIDONE K30
celecoxib drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
celecoxib drug variants containing POVIDONES
celecoxib drug variants not containing POVIDONES
Excipient focus: PROPYL GALLATE
celecoxib drug variants containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing PROPYL GALLATE
Excipient focus: PROPYLENE GLYCOL
celecoxib drug variants containing PROPYLENE GLYCOL
celecoxib drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
celecoxib drug variants containing SHELLAC
celecoxib drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
celecoxib drug variants containing SILICON DIOXIDE
celecoxib drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
celecoxib drug variants containing SODIUM HYDROXIDE
celecoxib drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
celecoxib drug variants containing SODIUM LAURYL SULFATE
celecoxib drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
celecoxib drug variants containing SODIUM STEARYL FUMARATE
celecoxib drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: SUCRALOSE
celecoxib drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing SUCRALOSE
Excipient focus: TALC
celecoxib drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | celecoxib | 65162-817 |
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
celecoxib drug variants containing TITANIUM DIOXIDE
celecoxib drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
celecoxib drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| REMEDYREPACK INC | celecoxib | 70518-4009 |
| Cadila Pharmaceuticals Limited | celecoxib | 71209-054 |
| Modavar Pharmaceuticals LLC | celecoxib | 72241-022 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
